Active Pharmaceutical Industry: Upcoming Technological Innovations | Active Pharmaceutical Ingredients Market - The Pos | Page 8

In 2015, the monoclonal antibodies segment account accounted for the largest share of
the global biotech active pharmaceutical ingredients market. Growing incidence of cancer,
increasing investments in R&D, technological advances in genetic sequencing and target
gene selection, and increasing application of mAbs in oncology reduced side effects as
compared to chemotherapy are some of the major factors responsible for the large share
of monoclonal antibodies in this market.
Based on geography, the global active pharmaceutical ingredients market is segmented
into North America, Europe, Asia, and the Rest of the World (RoW). North America is
expected to account for the largest share of the market by the end of 2016. This large
share can be attributed to various factors including increasing incidence of chronic
diseases, increasing focus of the government on the growing adoption of generic drugs,
rising demand for biologics and specialty drugs, and technological advances in API
manufacturing.
https://www.marketsandmarkets.com/Market-Reports/API-Market-263.html